The main findings of this article determined that while both market situations and firm characteristics are important in determining when pharmaceutical companies will develop and release new drugs, the interaction between these two primary forces is fundamental in this determination. Specifically, pharmaceutical companies are much more likely to launch products in new markets that more closely resemble the situations in their home markets. This is even more true when the markets are geographically and politically foreign, and not simply based around a different type of drug. Also, pharmaceutical companies are more likely to enter into competition with incumbent product producers that are foreign-based than with domestic competitors.
This study provided a lot of insight into how the pharmaceutical world works in general, as...
I also learned how much variation there can be from company to company in the pharmaceutical sector, and the differences that different countries have in pharmaceutical production, as well. Mostly, this article reminded me how essential market functions have become, even -- and perhaps especially -- in the profit-driven sectors of the healthcare industry.
I have no real criticisms for this author; I believe that the research is very sound and the conclusions valid. The graphs and tables used helped to clarify both the raw data and the point that the author was trying to make, leaving every aspect of this study sufficiently explained. I also have no questions; I believe this article covered everything it set out to in an exemplary fashion.
